![Mette Thorn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Mette Thorn worked as a Senior Vice President-Preclinical Development at Expres2ion Biotech Holding AB from 2021 to 2023.
She received a graduate and doctorate degree from the Technical University of Denmark.
Antiguos cargos conocidos de Mette Thorn.
| Empresas | Cargo | Fin |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Director Técnico/Científico/I+D | 29/09/2023 |
Formación de Mette Thorn.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
7
Relaciones de 1er grado
2
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
- Bolsa de valores
- Insiders
- Mette Thorn
